Literature DB >> 2259468

Centrally injected neuropeptide Y (13-36) produces vasopressor effects and antagonizes the vasodepressor action of neuropeptide Y (1-36) in the awake male rat.

J A Aguirre1, K Fuxe, L F Agnati, G von Euler.   

Abstract

Intraventricular injections of the Y2 neuropeptide Y (NPY) receptor agonist porcine NPY (13-36) (pNPY (13-36); 25-3000 pmol) produced a dose-dependent increase (up to 14%; ED50 value of 0.3 nmol for overall effects and 0.97 nmol for the peak effects) in mean arterial blood pressure in the awake, unrestrained male rat without affecting heart rate. Furthermore, a subthreshold dose of pNPY (13-36) (25 pmol) counteracted the vasodepressor action of the parent compound pNPY (1-36) (75 pmol), which also acts at NPY receptors of the Y1 type. These results suggest that NPY receptors of the Y1 and Y2 type have opposing actions in central cardiovascular regulation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2259468     DOI: 10.1016/0304-3940(90)90235-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

Review 1.  Receptor-receptor interactions as an integrative mechanism in nerve cells.

Authors:  M Zoli; L F Agnati; P B Hedlund; X M Li; S Ferré; K Fuxe
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

2.  On the existence and function of galanin receptor heteromers in the central nervous system.

Authors:  Kjell Fuxe; Dasiel O Borroto-Escuela; Wilber Romero-Fernandez; Alexander O Tarakanov; Feliciano Calvo; Pere Garriga; Mercé Tena; Manuel Narvaez; Carmelo Millón; Concepción Parrado; Francisco Ciruela; Luigi F Agnati; José A Narvaez; Zaida Díaz-Cabiale
Journal:  Front Endocrinol (Lausanne)       Date:  2012-10-26       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.